Maneeshika Madduri, PhD

Maneeshika is an investor at Samsung Next, one of Samsung’s Venture arms, and focuses primarily on health tech investing. Maneeshika has led multiple deals ranging from pre-seed to Series B, including Doctronic, Xlue AI, Cordance Medical, and Beacon Biosignals. Her background is in engineering and she previously worked at Sandia National Labs and Cala Health. Maneeshika received her BS and MS in Electrical Engineering from Stanford University and her PhD from the University of Washington.